Skip to main content
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1988 Oct;64(5):335–338. doi: 10.1136/sti.64.5.335

Intermittent local prophylaxis against recurrent vaginal candidosis.

T E Bushell 1, E G Evans 1, J D Meaden 1, J D Milne 1, D W Warnock 1
PMCID: PMC1194255  PMID: 3060424

Abstract

Women with recurrent vaginal candidosis were treated until the infection cleared and were then given one clotrimazole 500 mg vaginal tablet a month or an identical placebo as prophylaxis. Of 21 women who received placebo, 16 developed symptoms or signs within three months, compared with nine of 17 women given active treatment. Women who relapsed were treated and then given active prophylaxis once a month. Of 30 women given such treatment, 13 relapsed within three months. Women who relapsed were treated and then given two clotrimazole 500 mg vaginal tablets a month. Of 17 women given prophylaxis twice a month, four developed symptoms or signs within three months, but 10 remained clear for 12 months. No appreciable difference was seen in the incidence of mycological recurrence between the different regimens; within three months over half the women in all treatment groups had become recolonised.

Full text

PDF
335

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen L. Single dose treatment of vaginal candidosis: comparison of clotrimazole and isoconazole. Br J Vener Dis. 1984 Feb;60(1):42–44. doi: 10.1136/sti.60.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Davidson F., Mould R. F. Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br J Vener Dis. 1978 Jun;54(3):176–183. doi: 10.1136/sti.54.3.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hay R. J. Ketoconazole: a reappraisal. Br Med J (Clin Res Ed) 1985 Jan 26;290(6464):260–261. doi: 10.1136/bmj.290.6464.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hopwood V., Warnock D. W., Milne J. D., Crowley T., Horrocks C. T., Taylor P. K. Evaluation of a new slide latex agglutination test for diagnosis of vaginal candidosis. Eur J Clin Microbiol. 1987 Aug;6(4):392–394. doi: 10.1007/BF02013092. [DOI] [PubMed] [Google Scholar]
  5. Milne J. D., Warnock D. W. Effect of simultaneous oral and vaginal treatment on the rate of cure and relapse in vaginal candidosis. Br J Vener Dis. 1979 Oct;55(5):362–365. doi: 10.1136/sti.55.5.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Milsom I., Forssman L. Treatment of vaginal candidosis with a single 500-mg clotrimazole pessary. Br J Vener Dis. 1982 Apr;58(2):124–126. doi: 10.1136/sti.58.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Sobel J. D. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol. 1985 Mar;65(3):435–440. [PubMed] [Google Scholar]
  8. Sobel J. D. Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med. 1986 Dec 4;315(23):1455–1458. doi: 10.1056/NEJM198612043152305. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES